Hippocampal neurogenesis, neurotrophic factors and depression: Possible therapeutic targets?

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 10, 2014, Pages 1708-1721

  Serafini, Gianluca ^a   Hayley, Shawn ^b   Pompili, Maurizio ^c   Dwivedi, Yogesh ^d   Brahmachari, Goutam ^e   Girardi, Paolo ^c   Amore, Mario ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CARLETON UNIVERSITY   (Canada)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e VISVA BHARATI UNIVERSITY   (India)

Author keywords

Antidepressant drugs; Hippocampal neurogenesis; Major depression; Neurotrophic factors; Therapeutic targets

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN; GLUCOCORTICOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROKININ; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; NERVE GROWTH FACTOR;

ARTICLE; BRAIN SIZE; CELL PROLIFERATION; CELL SURVIVAL; DISABILITY; DISEASE ASSOCIATION; GLIA CELL; HIPPOCAMPAL CA3 REGION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NERVE STIMULATION; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NEUROTROPISM; NUCLEAR MAGNETIC RESONANCE IMAGING; STRESS; SYNAPTOGENESIS; ANIMAL; DEPRESSION; HIPPOCAMPUS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DEPRESSION; HIPPOCAMPUS; HUMANS; NERVE GROWTH FACTORS; NEUROGENESIS;

EID: 84924162021     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527313666141130223723     Document Type: Article

References (193)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289(23): 3095-105.
2. Pompili M, Innamorati M, Gonda X, et al. Affective temperaments and hopelessness as predictors of health and social functioning in mood disorder patients: a prospective follow-up study. J Affect Disord 2013a; 150(2): 216-22.
3. Serafini G, Pompili M, Innamorati M, et al. The role of microRNAs in synaptic plasticity, major affective disorders and suicidal behavior. Neurosci Res 2012; 73(3): 179-90.
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367(9524): 1747-57.
5. Fava M, Rush AJ, Wisniewski SR, et al. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry 2006; 163(7): 1161-72.
6. Petersen T, Gordon JA, Kant A, et al. Treatment resistant depression and axis I co-morbidity. Psychol Med 2001; 31(7): 1223-39.
7. Yu H, Wang DD, Wang Y, et al. Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci 2012; 32(12): 4092-101.
8. Tsai SJ, Hong CJ, Liou YJ. Effects of BDNF polymorphisms on antidepressant action. Psychiatry Investig 2010; 7(4): 236-42.
9. Murrough JW, Charney DS. Is there anything really novel on the antidepressant horizon? Curr Psychiatry Rep 2012; 14(6): 643-9.
10. Belmaker RH. The future of depression psychopharmacology. CNS Spectr 2008; 13(8): 682-7.
11. Rush AJ, Trivedi MH, Wisniewski SR, et al. STAR*D Study Team: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006; 354: 1231-42.
12. Serafini G, Pompili M, Innamorati M, et al. Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression. Curr Pharm Des 2013a; 19(10): 1898-922.
13. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46(9): 1181-91.
14. Soeiro-de-Souza MG, Dias VV, Figueira ML, et al. Translating neurotrophic and cellular plasticity: from pathophysio-logy to improved therapeutics for bipolar disorder. Acta Psychiatr Scand 2012; 126(5): 332-41.
15. Eriksson PS, Perfilieva E, Björk-Eriksson T, et al. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4(11): 1313-7.
16. Kempermann G, Kronenberg G. Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 2003; 54(5): 499-503.
17. Belda X, Rotllant D, Fuentes S, et al. Exposure to severe stressors causes long-lasting dysregulation of resting and stress-induced activation of the hypothalamic-pituitary-adrenal axis. Ann NY Acad Sci 2008; 1148: 165-73.
18. Perez-Cruz C, Simon M, Czéh B, Flügge G, Fuchs E. Hemispheric differences in basilar dendrites and spines of pyramidal neurons in the rat prelimbic cortex: activity-and stressinduced changes. Eur J Neurosci 2009; 29(4): 738-47.
19. Perez-Cruz C, Müller-Keuker JI, Heilbronner U, Fuchs E, Flügge G. Morphology of pyramidal neurons in the rat prefrontal cortex: lateralized dendritic remodeling by chronic stress. Neural Plast 2007; 2007: 46276.
20. Tanti A, Belzung C. Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific? Neuroscience 2013; 252: 234-52.
21. Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004; 5(1): 11-25.
22. Castrén E, Võikar V, Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007; 7(1): 18-21.
23. Bessa JM, Ferreira D, Melo I, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 14(8): 764-73.
24. Sairanen M, O'Leary OF, Knuuttila JE, Castrén E. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 2007; 144(1): 368-74.
25. McEwen BS, Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol 2004; 14(Suppl 5): S497-502.
26. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001; 35(2): 5-49.
27. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008; 33(1): 88-109.
28. Reznikov LR, Fadel JR, Reagan LP. Glutamate-mediated neuroplasticity deficits in mood disorders. In: Costa e Silva JA, Macher JP, Olie JP, Eds. Neuroplasticity: new biochemical mechanisms. London: Springer; 2009; pp. 13-26.
29. Kasper S, McEwen BS. Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs 2008; 22(1): 15-26.
30. Reagan LP, Rosell DR, Wood GE, et al. Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci USA 2004; 101(7): 2179-84.
31. Branchi I, Santarelli S, Capoccia S, et al. Antidepressant treatment outcome depends on the quality of the living environment: a preclinical investigation in mice. PLoS ONE 2013; 8(4): e62226.
32. Hutchinson AN, Deng JV, Cohen S, West AE. Phosphorylation of MeCP2 at Ser421 contributes to chronic antidepressant action. J Neurosci 2012; 32(41): 14355-63.
33. Wartman BC, Holahan MR. The impact of multiple memory formation on dendritic complexity in the hippocampus and anterior cingulate cortex assessed at recent and remote time points. Front Behav Neurosci 2014; 8: 128.
34. Beer Z, Chwiesko C, Sauvage MM. Processing of spatial and nonspatial information reveals functional homogeneity along the dorso-ventral axis of CA3, but not CA1. Neurobiol Learn Mem 2014; 111: 56-64.
35. Kanoski SE, Hayes MR, Greenwald HS, et al. Hippocampal leptin signaling reduces food intake and modulates food-related memory processing. Neuropsychopharmacology 2011; 36(9): 1859-70.
36. Morales P, Simola N, Bustamante D, et al. Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, nonspatial workingmemory and anxiety in rats. Exp Brain Res 2010; 202(1): 1-14.
37. Stupien G, Florian C, Roullet P. Involvement of the hippocampal CA3-region in acquisition and in memory consolidation of spatial but not in object information in mice. Neurobiol Learn Mem 2003; 80(1): 32-41.
38. Dranovsky A, Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 2006; 59(12): 1136-43.
39. Popov VI, Bocharova LS. Hibernation-induced structural changes in synaptic contacts between mossy fibres and hippocampal pyramidal neurons. Neuroscience 1992; 48(1): 53-62.
40. Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 1990; 531(1-2): 225-31.
41. Carvalho LA, Garner BA, Dew T, Fazakerley H, Pariante CM. Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms. Eur Neuropsychopharmacol 2010; 20(6): 379-87.
42. Eiland L, McEwen BS. Early life stress followed by subsequent adult chronic stress potentiates anxiety and blunts hippocampal structural remodeling. Hippocampus 2012; 22(1): 82-91.
43. Sousa N, Lukoyanov NV, Madeira MD, Almeida OF, Paula-Barbosa MM. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000; 97(2): 253-66.
44. Magariños AM, McEwen BS, Flügge G, Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 1996; 16(10): 3534-40.
45. Frodl T, Carballedo A, Hughes MM, et al. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl Psychiatry 2012; 2: e88.
46. Frodl T, Schaub A, Banac S, et al. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 2006; 31(5): 316-23.
47. Cole J, Costafreda SG, McGuffin P, Fu CH. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. J Affect Disord 2011; 134(1-3): 483-7.
48. Stockmeier CA, Mahajan GJ, Konick LC, et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 2004; 56: 640-50.
49. Lucassen PJ, Muller MB, Holsboer F, et al. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 2001; 158: 453-68.
50. Roy M, Sapolsky RM. The exacerbation of hippocampal excitotoxicity by glucocorticoids is not mediated by apoptosis. Neuroendocrinology 2003; 77: 24-31.
51. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925-35.
52. Muller MB, Lucassen PJ, Yassouridis A, et al. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 2001; 14: 1603-12.
53. Czéh B, Lucassen PJ. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci 2007; 257(5): 250-60.
54. D'Sa C, Duman RS. Antidepressants and neuroplasticity. Bipolar Disord 2002; 4(3): 183-94.
55. Spalding KL, Bergmann O, Alkass K, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell 2013; 153(6): 1219-27.
56. Andrade C, Rao NS. How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry 2010; 52(4): 378-86.
57. Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011; 476(7361): 458-61.
58. Groves JO, Leslie I, Huang GJ, et al. Ablating adult neurogenesis in the rat has no effect on spatial processing: evidence from a novel pharmacogenetic model. PLoS Genet 2013; 9(9): e1003718.
59. Surget A, Saxe M, Leman S, et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008; 64: 293-301.
60. Vollmayr B, Simonis C, Weber S, Gass P, Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 2003; 54(10): 1035-40.
61. Ge S, Yang CH, Hsu KS, Ming GL, Song H. A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain. Neuron 2007; 54(4): 559-66.
62. Jayatissa MN, Henningsen K, West MJ, Wiborg O. Decreased cell proliferation in the dentate gyrus does not associate with development of anhedonic-like symptoms in rats. Brain Res 2009; 1290: 133-41.
63. Mahar I, Tan S, Davoli MA, et al. Subchronic peripheral neuregulin-1 increases ventral hippocampal neurogenesis and induces antidepressant-like effects. PLoS One 2011; 6(10): e26610.
64. Mahar I, Bambico FR, Mechawar N, Nobrega JN. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev 2014; 38(10): 173-92.
65. Cooper B, Fuchs E, Flügge G. Expression of the axonal membrane glycoprotein M6a is regulated by chronic stress. PLoS One 2009; 4(1): e3659.
66. Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 2011; 13(1): 22-37.
67. Musazzi L, Milanese M, Farisello P, et al. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS One 2010; 5: e8566.
68. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003; 160(9): 1554-65.
69. Fuchs E. Animal models of depression. In: Olie JP, Costa e Silva JA, Macher JP, Eds. Neuroplasticity: A New Approach to the Pathophysiology of Depression. London: Science Press Ltd; 2004; pp. 39-50.
70. Evans J, Sun Y, McGregor A, Connor B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 2012; 63(8): 1315-26.
71. Llorens-Martín M, Trejo JL. Mifepristone prevents stress-induced apoptosis in newborn neurons and increases AMPA receptor expression in the dentate gyrus of C57/BL6 mice. PLoS One 2011; 6(8): e28376.
72. Lagace DC, Donovan MH, DeCarolis NA, et al. Adult hippocampal neurogenesis is functionally important for stressinduced social avoidance. Proc Natl Acad Sci USA 2010; 107(9): 4436-41.
73. Chigr F, Rachidi F, Segura S, et al. Neurogenesis inhibition in the dorsal vagal complex by chronic immobilization stress in the adult rat. Neuroscience 2009; 158(2): 524-36.
74. Toth E, Gersner R, Wilf-Yarkoni A, et al. Age-dependent effects of chronic stress on brain plasticity and depressive behavior. J Neurochem 2008; 107(2): 522-32.
75. Li S, Wang C, Wang W, et al. Chronic mild stress impairs cognition in mice: from brain homeostasis to behavior. Life Sci 2008a; 82(17-18): 934-42.
76. Lee KJ, Kim SJ, Kim SW, et al. Chronic mild stress decreases survival, but not proliferation, of new-born cells in adult rat hippocampus. Exp Mol Med 2006; 38(1): 44-54.
77. Greisen MH, Altar CA, Bolwig TG, Whitehead R, Wörtwein G. Increased adult hippocampal brain-derived neurotrophic factor and normal levels of neurogenesis in maternal separation rats. J Neurosci Res 2005; 79(6): 772-8.
78. Rosenbrock H, Koros E, Bloching A, Podhorna J, Borsini F. Effect of chronic intermittent restraint stress on hippocampal expression of marker proteins for synaptic plasticity and progenitor cell proliferation in rats. Brain Res 2005; 1040(1-2): 55-63.
79. Campos AC, Vaz GN, Saito VM, Teixeira AL. Further evidence for the role of interferon-gamma on anxiety-and depressive-like behaviors: Involvement of hippocampal neurogenesis and NGF production. Neurosci Lett 2014; 578: 100-5.
80. Naumenko VS, Kondaurova EM, Bazovkina DV, et al. Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains. Neuroscience 2012; 214: 59-67.
81. Blugeot A, Rivat C, Bouvier E, Molet J, et al. Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci 2011; 31(36): 12889-99.
82. Gonul AS, Kitis O, Eker MC, et al. Association of the brainderived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. World J Biol Psychiatry 2011; 12(2): 110-8.
83. Schmidt HD, Duman RS. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010; 35(12): 2378-91.
84. Eker C, Kitis O, Taneli F, et al. Correlation of serum BDNF levels with hippocampal volumes in first episode, medication-free depressed patients. Eur Arch Psychiatry Clin Neurosci 2010; 260(7): 527-33.
85. Taliaz D, Stall N, Dar DE, Zangen A. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry 2010; 15(1): 80-92.
86. Kronenberg G, Kirste I, Inta D, et al. Reduced hippocampal neurogenesis in the GR(+/-) genetic mouse model of depression. Eur Arch Psychiatry Clin Neurosci 2009; 259(8): 499-504.
87. Lee JS, Jang DJ, Lee N, et al. Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviors. J Neurosci 2009; 29(26): 8493-505.
88. Pollak DD, Monje FJ, Zuckerman L, et al. An animal model of a behavioral intervention for depression. Neuron 2008; 60(1): 149-61.
89. Li Y, Luikart BW, Birnbaum S, et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008b; 59(3): 399-412.
90. Thakker-Varia S, Krol JJ, Nettleton J, et al. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci 2007; 27(45): 12156-67.
91. Duric V, McCarson KE. Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J Pain 2006; 7(8): 544-55.
92. Gage FH, Thompson RG. Differential distribution of norepinephrine and serotonin along the dorsal-ventral axis of the hippocampal formation. Brain Res Bull 1980; 5(6): 771-3.
93. Gasbarri A, Verney C, Innocenzi R, Campana E, Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res 1994; 668(1-2): 71-9.
94. Brezun JM, Daszuta A. Serotonergic reinnervation reverses lesioninduced decreases in PSA-NCAM labeling and proliferation of hippocampal cells in adult rats. Hippocampus 2000a; 10(1): 37-46.
95. Brezun JM, Daszuta A. Serotonin may stimulate granule cell proliferation in the adult hippocampus, as observed in rats grafted with foetal raphe neurons. Eur J Neurosci 2000b; 12(1): 391-6.
96. Banasr M, Hery M, Printemps R, Daszuta A. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 2004; 29(3): 450-60.
97. Diaz SL, Doly S, Narboux-Nême N, et al. 5-HT(2B) receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry 2012; 17(2): 154-63.
98. Ferres-Coy A, Pilar-Cuellar F, Vidal R, et al. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Transl Psychiatry 2013; 3: e211.
99. Hoglinger GU, Rizk P, Muriel MP, et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 2004; 7(7): 726-35.
100. Yang P, Arnold SA, Habas A, Hetman M, Hagg T. Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice. J Neurosci 2008; 28(9): 2231-41.
101. Egeland M, Zhang X, Millan MJ, Mocaer E, Svenningsson P. Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice. J Neurochem 2012; 123(5): 811-23.
102. Veena J, Rao BS, Srikumar BN. Regulation of adult neurogenesis in the hippocampus by stress, acetylcholine and dopamine. J Nat Sci Biol Med 2011; 2(1): 26-37.
103. Guiard BP, El Mansari M, Blier P. Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus. Mol Pharmacol 2008a; 74(5): 1463-75.
104. Guiard BP, El Mansari M, Merali Z, Blier P. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol 2008b; 11: 625-39.
105. Kulkarni VA, Jha S, Vaidya VA. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur J Neurosci 2002; 16(10): 2008-12.
106. Jhaveri DJ, Mackay EW, Hamlin AS, et al. Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J Neurosci 2010; 30(7): 2795-806.
107. Masuda T, Nakagawa S, Boku S, et al. Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through beta2 receptor. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36(1): 44-51.
108. Rizk P, Salazar J, Raisman-Vozari R, et al. The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 2006; 31(6): 1146-57.
109. Hayley S, Litteljohn D. Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci 2013; 7: 218.
110. Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 2008; 117(1): 30-51.
111. Jin K, Zhu Y, Sun Y, et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2002; 99(18): 11946-50.
112. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 2000; 20(8): 2896-903.
113. Pinnock SB, Blake AM, Platt NJ, Herbert J. The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine. PLoS One 2010; 5(10): e13652.
114. Pae CU, Marks DM, Han C, Patkar AA, Steffens D. Does neurotropin-3 have a therapeutic implication in major depression? Int J Neurosci 2008; 118(11): 1515-22.
115. Larsen MH, Mikkelsen JD, Hay-Schmidt A, Sandi C. Regulation of brainderived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res 2010; 44(13): 808-16.
116. Shi SS, Shao SH, Yuan BP, Pan F, Li ZL. Acute stress and chronic stress change brain-derived neurotrophic factor (BDNF) and tyrosine kinase-coupled receptor (TrkB) expression in both young and aged rat hippocampus. Yonsei Med J 2010; 51(5): 661-71.
117. Hanson ND, Owens MJ, Nemeroff CB. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011; 36(13): 2589-602.
118. Gersner R, Toth E, Isserles M, Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biol Psychiatry 2010; 67(2): 125-32.
119. Czubak A, Nowakowska E, Kus K, et al. Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol Rep 2009; 61(6): 1017-23.
120. Duman CH, Schlesinger L, Terwilliger R, et al. Peripheral insulinlike growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav Brain Res 2009; 198(2): 366-71.
121. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995; 14(4): 717-30.
122. Glasper ER, Llorens-Martin MV, Leuner B, Gould E, Trejo JL. Blockade of insulin-like growth factor-I has complex effects on structural plasticity in the hippocampus. Hippocampus 2010; 20(6): 706-12.
123. Sun Y, Jin K, Childs JT, et al. Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev Biol 2006; 289(2): 329-35.
124. Warner-Schmidt JL, Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA 2007; 104(11): 4647-52.
125. Schloesser RJ, Jimenez DV, Hardy NF, et al. Atrophy of pyramidal neurons and increased stress-induced glutamate levels in CA3 following chronic suppression of adult neurogenesis. Brain Struct Funct 2014; 219(3): 1139-48.
126. Fuchs E. Neuroplasticity: a new approach to the pathophysiology of depression. In: Costa e Silva JA, Macher JP, Olie JP, Eds. Neuroplasticity: new biochemical mechanisms. London: Springer; 2009; pp. 1-12.
127. Holick KA, Lee DC, Hen R, Dulawa SC. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 2008; 33(2): 406-17.
128. Huang GJ, Bannerman D, Flint J. Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice. Mol Psychiatry 2008; 13(2): 119-21.
129. Navailles S, Hof PR, Schmauss C. Antidepressant drug-induced stimulation of mouse hippocampal neurogenesis is age-dependent and altered by early life stress. J Comp Neurol 2008; 509(4): 372-81.
130. Boldrini M, Hen R, Underwood MD, et al. Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. Biol Psychiatry 2012; 72(7): 562-71.
131. Boldrini M, Underwood MD, Hen R, et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009; 34(11): 2376-89.
132. Perera TD, Dwork AJ, Keegan KA, et al. Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS One 2011; 6(4): e17600.
133. Wang JW, David DJ, Monckton JE, Battaglia F, Hen R. Chronic fluoxetine stimulates maturation and synaptic plasticity of adultborn hippocampal granule cells. J Neurosci 2008; 28(6): 1374-84.
134. Surget A, Tanti A, Leonardo ED, et al. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 2011; 16(12): 1177-88.
135. Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007; 18: 391-418.
136. Lucassen PJ, Heine VM, Muller MB, et al. Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets 2006; 5: 531-46.
137. Norrholm SD, Ouimet CC. Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse 2001; 42: 151-63.
138. Hajszan T, Dow A, Warner-Schmidt JL, et al. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol Psychiatry 2009; 65: 392-400.
139. Anacker C, Zunszain PA, Cattaneo A, et al. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry 2011; 16(7): 738-50.
140. Dagyte G, Trentani A, Postema F, et al. The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats. CNS Neurosci Therap 2010; 16: 195-207.
141. David DJ, Samuels BA, Rainer Q, et al. Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009; 62(4): 479-93.
142. Huang GJ, Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol Psychiatry 2006; 59(7): 619-24.
143. Fitzsimons CP, van Hooijdonk LW, Morrow JA, et al. Antiglucocorticoids, neurogenesis and depression. Mini Rev Med Chem 2009; 9(2): 249-64.
144. Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008; 31(9): 464-8.
145. Pariante CM, Hye A, Williamson R, et al. The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 2003a; 28(6): 1553-61.
146. Pariante CM, Kim RB, Makoff A, Kerwin RW. Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br J Pharmacol 2003b; 139(9): 1111-8.
147. Hu P, Oomen C, van Dam AM, et al. A single-day treatment with mifepristone is sufficient to normalize chronic glucocorticoid induced suppression of hippocampal cell proliferation. PLoS One 2012; 7(10): e46224.
148. Nollet M, Gaillard P, Tanti A, et al. Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression. Neuropsychopharmacology 2012; 37(10): 2210-21.
149. Rocher C, Spedding M, Munoz C, Jay TM. Acute stressinduced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004; 14: 224-9.
150. Czéh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001; 98(22): 12796-801.
151. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20(24): 9104-10.
152. Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 2013; 31(6): 761-77.
153. Halpain S, Hipolito A, Saffer L. Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci 1998; 18(23): 9835-44.
154. Virgin CE, Ha TP, Packan DR, et al. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem 1991(4); 57: 1422-8.
155. Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992; 222(1): 157-62.
156. Magariños AM, McEwen BS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 1995; 69(1): 83-8.
157. Kobayashi K, Ikeda Y, Sakai A, et al. Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc Natl Acad Sci USA 2010; 107: 8434-9.
158. Hayashi H, Doi M, Onoue Y, et al. Investigation on the mechanisms for the suppression of cell proliferation in the dentate gyrus of the hippocampus in ACTH treated rats. Yakugaku Zasshi 2012; 132(2): 173-8.
159. Pentkowski NS, Blanchard DC, Lever C, Litvin Y, Blanchard RJ. Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats. Eur J Neurosci 2006; 23(8): 2185-96.
160. Nettles KW, Pesold C, Goldman MB. Influence of the ventral hippocampal formation on plasma vasopressin, hypothalamicpituitary-adrenal axis, and behavioral responses to novel acoustic stress. Brain Res 2000; 858(1): 181-90.
161. Malki K, Lourdusamy A, Binder E, et al. Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression. Pharmacogenet Genomics 2012; 22(11): 765-76.
162. Franklin TB, Saab BJ, Mansuy IM. Neural mechanisms of stress resilience and vulnerability. Neuron 2012; 75(5): 747-61.
163. Lin YL, Lin SY, Wang S. Prenatal lipopolysaccharide exposure increases anxiety-like behaviors and enhances stressinducedcorticosterone responses in adult rats. Brain Behav Immun 2012; 26(3): 459-68.
164. Raghupathi RK, McGonigle P. Differential effects of three acute stressors on the serotonin 5-HT1A receptor system in rat brain. Neuroendocrinology 1997; 65: 246-58.
165. Svenningsson P, Bateup H, Qi H, Takamiya K, et al. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 2007; 26(12): 3509-17.
166. Maeng S, Zarate CA Jr, Du J, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alphaamino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008; 63(4): 349-52.
167. Du J, Suzuki K, Wei Y, et al. The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 2007; 32(4): 793-802.
168. Svenningsson P, Tzavara ET, Witkin JM, et al. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc Natl Acad Sci USA 2002; 99(5): 3182-7.
169. Lucassen PJ, Fuchs E, Czéh B. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 2004; 55: 789-96.
170. Popoli M, Vocaturo C, Perez J, Smeraldi E, Racagni G. Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. Mol Pharmacol 1995; 48(4): 623-9.
171. Duncan GE, Knapp DJ, Johnson KB, Breese GR. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. J Pharmacol Exp Ther 1996; 277(2): 1076-89.
172. Banasr M, Soumier A, Hery M, Mocaer E, Daszuta A. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 2006; 59(11): 1087-96.
173. Pompili M, Serafini G, Innamorati M, et al. Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review. World J Biol Psychiatry 2013b; 14(6): 412-31.
174. Soumier A, Banasr M, Lortet S, et al. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology 2009; 34(11): 2390-403.
175. Tardito D, Milanese M, Bonifacino T, et al. Blockade of stressinduced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptordependent pathways. BMC Neurosci 2010; 11: 68.
176. Calabrese F, Molteni R, Cattaneo A, et al. Long term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. Mol Pharmacol 2010; 77(5): 846-53.
177. Conboy L, Tanrikut C, Zoladz PR, et al. The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats. Int J Neuropsychopharmacol 2009; 12(3): 329-41.
178. Molteni R, Calabrese F, Pisoni S, et al. Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration. World J Biol Psychiatry 2010; 11(2): 148-53.
179. Morley-Fletcher S, Mairesse J, Soumier A, et al. Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. Psychopharmacology 2011; 217(3): 301-13.
180. Païzanis E, Renoir T, Lelievre V, et al. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptorimpaired mice. Int J Neuropsychopharmacol 2010; 13(6): 759-74.
181. Dwivedi Y. Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications. Dialogues Clin Neurosci 2014; 16(1): 43-61.
182. Launay JM, Mouillet-Richard S, Baudry A, Pietri M, Kellermann O. Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl Psychiatry 2011; 1: e56.
183. Serafini G, Pompili M, Hansen KF, et al. The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p. Cell Mol Neurobiol 2014; 34(1): 17-30.
184. Serafini G, Pompili M, Hansen KF, et al. MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior? Front Cell Neurosci 2013b; 7: 208.
185. Carr GV, Lucki I. The role of serotonin receptor subtypes intreating depression: a review of animal studies. Psychopharmacology 2011; 213(2-3): 265-87.
186. De Vry J. 5-HT1A receptor agonists: recentdevelopments and controversial issues. Psychopharmacology 1995; 121(1): 1-26.
187. Rosenzweig-Lipson S, Dunlop J, Marquis KL. 5-HT2C receptor agonists as an innovative approach for psychiatric disorders. Drug News Perspect 2007; 20(9): 565-71.
188. Celada P, Puig MV, Artigas F. Serotonin modulation of cortical neurons and networks. Front Integr Neurosci 2013; 7: 25.
189. Moreau JL, Bös M, Jenck F, et al. 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropsychopharmacol 1996; 6(3): 169-75.
190. Kiuchi T, Lee H, Mikami T. Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice. Neuroscience 2012; 207: 208-17.
191. Oomen CA, Mayer JL, de Kloet ER, Joels M, Lucassen PJ. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. Eur J Neurosci 2007; 26(12): 3395-401.
192. Mayer JL, Klumpers L, Maslam S, et al. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the corticosterone-induced reduction of adult hippocampal neurogenesis. J Neuroendocrinol 2006; 18(8): 629-31.
193. Wainwright SR, Galea LA. The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSANCAM within the hippocampus. Neural Plast 2013; 2013: 805497.